REGNRegeneron PharmaceuticalsHealth Care
$614.78EarningsJul 30, 2026
1D—1W—1M—3M—1Y—
Market cap$66.2BCompany infoRevenue$14.9B52-wk range$520 – $812IndustryBiotechnologyWebsiteregeneron.comRelated
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +17.7% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E15.0×7788
9
28
P / S4.4×3039
4
9
P / FCF15.9×6066
9
38
EV / EBITDA10.3×7483
7
22
P / E (fwd)13.2×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin84.5%9590
83%
86%
Operating margin24.3%7476
24%
56%
Net margin29.6%9193
29%
52%
ROE14.5%5259
14%
47%
ROIC9.3%5253
9%
37%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.068778
0.1
0.1
Net debt / EBITDA-1.2×8579
Current ratio3.568980
Interest coverage75.6×8881
Per shareTTM, with year-over-year change
Revenue / share$138.53▲ +6%
EPS (diluted)$41.04▲ +4%
FCF / share$38.58▲ +38%
Est. EPS growth (fwd)+17%